HopeStage
Back to all studies
Active Not RecruitingNCT03540745

Nexalin electrical stimulation alongside substance use treatment

About this titleRead the official source — NCT03540745
Device studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Belle MeadSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 11, 2018
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
14
Sponsor
University of Arizona
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03540745
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Nexalin Electrical Brain Stimulation as an Adjunctive Therapy for Substance Dependence

Recruitment & locations

Not recruiting

Belle Mead

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Arizona, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies